The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characteristics of SMAD4 alterations in an immune-cold genomic subtype of biliary tract cancers in the Indian population.
 
Aditya Shreenivas
Consulting or Advisory Role - Bayer; Lilly; Taiho Pharmaceutical (Inst)
Research Funding - Caris Life Sciences (Inst); Foundation Medicine; Natera (Inst)
(OPTIONAL) Uncompensated Relationships - Datar Cancer Genetics
 
Darshana Patil
Employment - Datar Cancer Genetics
Leadership - Datar Cancer Genetics
Stock and Other Ownership Interests - Datar Cancer Genetics
 
Irene George
No Relationships to Disclose
 
Janani Sambath
No Relationships to Disclose
 
Shambhavi Singh
No Relationships to Disclose
 
Chetan Madre
No Relationships to Disclose
 
Anjali Parab
No Relationships to Disclose
 
Soumil Vyas
No Relationships to Disclose
 
Pritam Kataria
No Relationships to Disclose
 
Darshit Shah
No Relationships to Disclose
 
Rajas Patel
No Relationships to Disclose
 
Niyati Shah
No Relationships to Disclose
 
Nitesh Rohatagi
No Relationships to Disclose
 
Ruturaj Deshpande
No Relationships to Disclose
 
Aakriti Datta
No Relationships to Disclose
 
Prashant Kumar
No Relationships to Disclose
 
Rajan Datar
Employment - Datar Cancer Genetics
 
Sewanti Limaye
Employment - Sir H N Reliance Foundation Hospital and Research Centre
Leadership - Iylon; Sir H N Reliance Foundation Hospital and Research Centre
Stock and Other Ownership Interests - Iylon
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; MSD; Novartis; Roche
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; MSD; Novartis; Roche